FDA
approval
· 2024-11-21
FDA Approved: KETOROLAC TROMETHAMINE — Supplemental Application (Hospira, Inc.)
Summary
FDA approves Hospira's supplemental application for ketorolac tromethamine, a generic NSAID. The approval pertains to a supplemental change to the product's app…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)